Featured Article

Comparison of Body Mass Index (BMI) in Patients with and without Type 2 Diabetes Remission

Jose Aug 05, 2026

Comparison between patients without and with T2D remission. BMI (A ...

Comparison between patients without and with T2D remission BMI A
Comparison between patients without and with T2D remission BMI A

Download scientific diagram | Comparison between patients without and with T2D remission . BMI ( A ), TWL (B), HbA1c (C), and HSI (D) during long-term follow-up. BMI , Body Mass Index; T2D , type 2 ...

PDF The Inflammation Spectrum of Monocytes in Relation to Obesity and Severity of Type 2
PDF The Inflammation Spectrum of Monocytes in Relation to Obesity and Severity of Type 2

Materials and Methods Ten patients without T2D remission (non-remitters) were matched to 10 patients with T2D remission (remitters) for age, sex, type of surgery, body weight, BMI , post-operative weight loss, duration from surgery and duration of T2D .

Decreased Weight Loss Following Bariatric Surgery in Patients with Type ...

Adjusted odds ratios ORs of log formed A isobutyrate and B
Adjusted odds ratios ORs of log formed A isobutyrate and B

T2D remission was assessed according to the ADA criteria. Results In the whole dataset, 92 patients were affected by T2D . Patients with T2D were older than patients without T2D (52 ± 9 vs 45 ± 11 years, p < 0.0001), but there were no differences in baseline BMI , sex, and type of intervention received.

We evaluated long-term T2D remission rates and annual T2D clinical and metabolic parameters up to 14 years after surgery. Predictors of remission were assessed using multivariate logistic regression. Patients were divided into 4 groups based on quartiles of total body weight loss percentage (%TBWL) to compare remission rates between groups.

Is your approach to T2D management up to date
Is your approach to T2D management up to date

Decreased Weight Loss Following Bariatric Surgery in Patients with Type ...

Results In the whole dataset, 92 patients were affected by T2D . Patients with T2D were older than patients without T2D (52 ± 9 vs 45 ± 11 years, p < 0.0001), but there were no differences in baseline BMI , sex, and type of intervention received.

This study provides a large, real-world analysis comparing four distinct definitions of T2D remission in over 14,000 individuals initiating GLP-1RA therapy. Herein, we quantify the frequency and duration of remission according to various definitions and identify consistent clinical predictors of remission . These included younger age, shorter diabetes duration, higher BMI , and fewer ...

Risk of type 2 diabetes mellitus in adult patients with atopic dermatitis Diabetes Research
Risk of type 2 diabetes mellitus in adult patients with atopic dermatitis Diabetes Research

Overview of Comparison Between Patients Without And With T2D Remission Bmi A

We previously reported results from ARMMS- T2D at 3 years, demonstrating that bariatric surgery is more effective and durable than medical/lifestyle intervention for type 2 diabetes remission , even in those with a BMI of 25 to less than 35. 9 Herein, we report long-term follow-up of participants in ARMMS- T2D at the primary end point of 7 years ...

Curbing or reversing high glycated hemoglobin (HbA1c) and body mass index ( BMI ) are two essential parts in the clinical management of type 2 diabetes ( T2D ). We delineated the changing patterns of the baseline HbA1c and BMI in patients with T2D from placebo-controlled randomised trials to reflect the unmet clinical needs.

Key Messages From 2 Recent Studies On NAFLD Severity In People With Type 2 Diabetes PanNASH
Key Messages From 2 Recent Studies On NAFLD Severity In People With Type 2 Diabetes PanNASH

Type 2 Diabetes Remission

There is also a strong dose-response relationship between body weight loss and diabetes remission ; every 1% decrease in body weight increases the probability of reaching remission by 2% (10). Loss of >10% of baseline body weight in the first year after diagnosis of type 2 diabetes is associated with a 70% higher chance of remission at 5 years (11).

mTORC1 syndrome TorS unified paradigm for diabetes metabolic syndrome Trends
mTORC1 syndrome TorS unified paradigm for diabetes metabolic syndrome Trends
Mitochondrial Dysfunction Oxidative Stress and Inter Organ Miscommunications in T2D Progression
Mitochondrial Dysfunction Oxidative Stress and Inter Organ Miscommunications in T2D Progression
Plasma biomarker data for T2D versus non T2D patients Error bars
Plasma biomarker data for T2D versus non T2D patients Error bars
Pancreatic beta cell decompensation and progression to T2D
Pancreatic beta cell decompensation and progression to T2D
Frontiers Obesity and type 2 diabetes mellitus connections in epidemiology pathogenesis
Frontiers Obesity and type 2 diabetes mellitus connections in epidemiology pathogenesis
Schematic diagram of the potential common components mechanisms
Schematic diagram of the potential common components mechanisms
1 year survival of older multimorbid patients with T2D n 490
1 year survival of older multimorbid patients with T2D n 490
Regulation of ROS and Nitrate production HUVEC were treated without
Regulation of ROS and Nitrate production HUVEC were treated without
Type 2 Diabetes Causes Symptoms and CBSE s Sugar Board Push
Type 2 Diabetes Causes Symptoms and CBSE s Sugar Board Push

Three-year data from the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS- T2D ) showed that diabetes remission occurred in 37.5% of participants after MBS (11).